Tearsheet

Warby Parker (WRBY)


Market Price (12/4/2025): $18.32 | Market Cap: $2.3 Bil
Sector: Health Care | Industry: Health Care Equipment

Warby Parker (WRBY)


Market Price (12/4/2025): $18.32
Market Cap: $2.3 Bil
Sector: Health Care
Industry: Health Care Equipment

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 13%
Weak multi-year price returns
3Y Excs Rtn is -53%
Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -7.9 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.9%
1 Megatrend and thematic drivers
Megatrends include E-commerce & Digital Retail, Experience Economy & Premiumization, and Sustainable Consumption. Themes include Direct-to-Consumer Brands, Show more.
  Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 32x, P/EPrice/Earnings or Price/(Net Income) is 4730x
2   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -4.1%
0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 13%
1 Megatrend and thematic drivers
Megatrends include E-commerce & Digital Retail, Experience Economy & Premiumization, and Sustainable Consumption. Themes include Direct-to-Consumer Brands, Show more.
2 Weak multi-year price returns
3Y Excs Rtn is -53%
3 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -7.9 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.9%
4 Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 32x, P/EPrice/Earnings or Price/(Net Income) is 4730x
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -4.1%

Valuation, Metrics & Events

WRBY Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Here are the key points for why Warby Parker's (WRBY) stock moved by -27.2% for the approximate time period from August 31, 2025, to December 4, 2025: 1. Warby Parker's Q3 2025 revenue fell short of analyst expectations, despite year-over-year growth. The company reported net revenue of $221.7 million, which, while a 15.2% increase from the prior year, missed analyst estimates of $224.3 million by 1.2%.

2. The company lowered its full-year 2025 revenue and adjusted EBITDA guidance. Warby Parker reduced its full-year revenue outlook to a midpoint of $872.5 million, a 1.3% decrease from its previous guidance and below analyst estimates. Full-year adjusted EBITDA guidance was also lowered to a midpoint of $99.5 million, which was below analyst estimates.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
WRBY Return---71%5%72%-24%-60%
Peers Return27%19%-24%5%-10%3%11%
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
WRBY Win Rate-33%50%50%58%60% 
Peers Win Rate40%35%29%35%27%32% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
WRBY Max Drawdown---76%-28%-19%-42% 
Peers Max Drawdown-40%-3%-31%-14%-29%-28% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: LMAT, CNMD, GPRO, DAVI, EMI.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/3/2025 (YTD)

How Low Can It Go

Unique KeyEventWRBYS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-83.7%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven514.0%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days

Compare to LMAT, CNMD, GPRO, DAVI, EMI


In The Past

Warby Parker's stock fell -83.7% during the 2022 Inflation Shock from a high on 11/17/2021. A -83.7% loss requires a 514.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Warby Parker (WRBY)

Better Bets than Warby Parker (WRBY)

Latest Trefis Analyses

Trade Ideas

Select past ideas related to WRBY. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
10.0%10.0%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.7%-7.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.9%6.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
11.5%11.5%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
8.9%8.9%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
10.0%10.0%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.7%-7.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.9%6.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
11.5%11.5%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
8.9%8.9%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Warby Parker

Peers to compare with:

Financials

WRBYLMATCNMDGPRODAVIEMIMedian
NameWarby Pa.LeMaitre.Conmed GoPro Davion H.Encore M. 
Mkt Price19.0884.9244.351.85--31.71
Mkt Cap2.31.91.40.3--1.6
Rev LTM8512411,347651--751
Op Inc LTM-862118-89--27
FCF LTM3866149-65--52
FCF 3Y Avg2941118-59--35
CFO LTM10773168-61--90
CFO 3Y Avg9048135-56--69

Growth & Margins

WRBYLMATCNMDGPRODAVIEMIMedian
NameWarby Pa.LeMaitre.Conmed GoPro Davion H.Encore M. 
Rev Chg LTM14.6%13.1%4.6%-27.4%--8.8%
Rev Chg 3Y Avg13.3%14.6%8.1%-17.3%--10.7%
Rev Chg Q15.2%11.4%6.7%-37.1%--9.0%
QoQ Delta Rev Chg LTM3.6%2.7%1.6%-12.9%--2.1%
Op Mgn LTM-0.9%25.7%8.8%-13.7%--3.9%
Op Mgn 3Y Avg-5.9%22.4%10.0%-10.4%--2.1%
QoQ Delta Op Mgn LTM1.3%2.4%-4.2%-2.9%---0.8%
CFO/Rev LTM12.6%30.4%12.4%-9.4%--12.5%
CFO/Rev 3Y Avg12.0%21.8%10.4%-6.9%--11.2%
FCF/Rev LTM4.4%27.5%11.1%-9.9%--7.7%
FCF/Rev 3Y Avg3.8%18.5%9.1%-7.2%--6.4%

Valuation

WRBYLMATCNMDGPRODAVIEMIMedian
NameWarby Pa.LeMaitre.Conmed GoPro Davion H.Encore M. 
Mkt Cap2.31.91.40.3--1.6
P/S4.08.21.10.5--2.5
P/EBIT-429.327.212.3-2.9--4.7
P/E4,729.937.222.7-2.8--30.0
P/CFO31.627.18.7-5.5--17.9
Total Yield0.0%3.6%6.1%-36.1%--1.8%
Dividend Yield0.0%0.9%1.7%0.0%--0.4%
FCF Yield 3Y Avg1.3%2.3%6.3%-19.7%--1.8%
D/E0.10.10.60.6--0.3
Net D/E-0.0-0.10.60.4--0.2

Returns

WRBYLMATCNMDGPRODAVIEMIMedian
NameWarby Pa.LeMaitre.Conmed GoPro Davion H.Encore M. 
1M Rtn-3.5%-2.1%-1.1%0.5%---1.6%
3M Rtn-24.5%-10.0%-15.8%25.0%---12.9%
6M Rtn-6.4%3.3%-21.0%169.6%---1.5%
12M Rtn-16.5%-18.4%-40.0%48.0%---17.4%
3Y Rtn2.9%85.0%-49.3%-66.6%---23.2%
1M Excs Rtn-3.5%-2.0%-1.1%0.6%---1.6%
3M Excs Rtn-30.1%-17.7%-23.9%21.4%---20.8%
6M Excs Rtn-21.1%-11.4%-35.7%154.9%---16.2%
12M Excs Rtn-28.9%-33.4%-52.8%36.9%---31.2%
3Y Excs Rtn-52.7%22.7%-116.3%-137.8%---84.5%

Financials

Price Behavior

Short Interest

Short Interest: As Of Date11142025
Short Interest: Shares Quantity10,936,463
Short Interest: % Change Since 103120257.9%
Average Daily Volume4,029,967
Days-to-Cover Short Interest2.71
Basic Shares Quantity122,963,000
Short % of Basic Shares8.9%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251106202510-Q 9/30/2025
6302025808202510-Q 6/30/2025
3312025508202510-Q 3/31/2025
12312024227202510-K 12/31/2024
93020241107202410-Q 9/30/2024
6302024808202410-Q 6/30/2024
3312024509202410-Q 3/31/2024
12312023229202410-K 12/31/2023
93020231108202310-Q 9/30/2023
6302023809202310-Q 6/30/2023
3312023509202310-Q 3/31/2023
12312022228202310-K 12/31/2022
93020221110202210-Q 9/30/2022
6302022811202210-Q 6/30/2022
3312022516202210-Q 3/31/2022
12312021318202210-K 12/31/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value
Value of
Held Shares
Form
0Briggs Teresa8132025Sell23.566,000141,3601,057,349Form
1Moon Youngme E5272025Sell19.9033,073658,1531,071,993Form
2Miller Steven CliveChief Financial Officer12132024Sell23.857,016167,3324,343,800Form